You are here

Videos

Importance of Molecular Monitoring in CML: How Deep, How Often, and How Should it Influence Therapy?

We Do Still Transplant CML, Don't We?

Immunology of CML and Immunomodulation

Prognostic biomarkers in CML

Making TFR Mainstream

2018 UK Patient Day:DESTINY clinical trial and stopping treatment, who and when? Prof Richard Clark

2018 UK Patient Day: Questions to Panel (Session 3)

2018 UK Patient Day: Questions to Panel (Session 2)

2018 UK Patient Day: Update on clinical trials and what’s new